Literature DB >> 18068955

Neural bases of dysphoria in early Huntington's disease.

Sergio Paradiso1, Beth M Turner, Jane S Paulsen, Ricardo Jorge, Laura L Boles Ponto, Robert G Robinson.   

Abstract

Psychiatric disorders, including disorders of emotion control, are common in Huntington's disease. The neurobiological mechanism of the increased rate of disorders of emotion control are not known. Emotion perception deficits have been reported in Huntington's disease, but studies of emotional experience have been limited. In the present study we aim to expand the research in emotion in Huntington's disease by examining the neural bases of induced dysphoria at an early stage of Huntington's disease. Ten Huntington's disease patients and 12 demographically matched healthy volunteers underwent [(15)O] water positron emission tomography while in a transient state of dysphoria induced by viewing negatively charged affect-laden stimuli. Both groups experienced dysphoric mood, but Huntington's disease patients responded to the stimuli with greater arousal, anger and fear than healthy controls. Induced dysphoric mood was associated with a widespread reduction of activity within the frontal and parietal lobes, thalamus, and cerebellum. These differences could not be explained based on the smaller gray matter volumes of the corresponding regions, although in Huntington's disease patients smaller caudate nucleus volumes predicted lower dorsal-lateral prefrontal activity. Areas of increased activity included the striate and extrastriate cortex, the left thalamus, the transverse temporal gyrus, and the posterior hippocampus. This study elucidates possible mechanisms contributing to psychiatric disturbances of emotion often found in patients with Huntington's disease.

Entities:  

Mesh:

Year:  2008        PMID: 18068955      PMCID: PMC3348657          DOI: 10.1016/j.pscychresns.2007.04.001

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  86 in total

1.  Cerebral blood flow changes associated with attribution of emotional valence to pleasant, unpleasant, and neutral visual stimuli in a PET study of normal subjects.

Authors:  S Paradiso; D L Johnson; N C Andreasen; D S O'Leary; G L Watkins; L L Ponto; R D Hichwa
Journal:  Am J Psychiatry       Date:  1999-10       Impact factor: 18.112

2.  Cortical magnetic resonance imaging changes in elderly inpatients with major depression.

Authors:  P V Rabins; G D Pearlson; E Aylward; A J Kumar; K Dowell
Journal:  Am J Psychiatry       Date:  1991-05       Impact factor: 18.112

3.  A direct demonstration of functional specialization in human visual cortex.

Authors:  S Zeki; J D Watson; C J Lueck; K J Friston; C Kennard; R S Frackowiak
Journal:  J Neurosci       Date:  1991-03       Impact factor: 6.167

Review 4.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

Authors:  G E Alexander; M D Crutcher; M R DeLong
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

5.  Left prefrontal glucose hypometabolism in the depressed state: a confirmation.

Authors:  J L Martinot; P Hardy; A Feline; J D Huret; B Mazoyer; D Attar-Levy; S Pappata; A Syrota
Journal:  Am J Psychiatry       Date:  1990-10       Impact factor: 18.112

6.  Presymptomatic neuropsychological impairment in Huntington's disease.

Authors:  G W Jason; E M Pajurkova; O Suchowersky; J Hewitt; C Hilbert; J Reed; M R Hayden
Journal:  Arch Neurol       Date:  1988-07

7.  A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.

Authors:  E W Almqvist; M Bloch; R Brinkman; D Craufurd; M R Hayden
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

8.  Prefrontal cortical blood flow and cognitive function in Huntington's disease.

Authors:  D R Weinberger; K F Berman; M Iadarola; N Driesen; R F Zec
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

9.  Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network.

Authors:  P W Corson; P Nopoulos; N C Andreasen; D Heckel; S Arndt
Journal:  Biol Psychiatry       Date:  1999-09-01       Impact factor: 13.382

10.  Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations.

Authors:  K R Krishnan; W M McDonald; P R Escalona; P M Doraiswamy; C Na; M M Husain; G S Figiel; O B Boyko; E H Ellinwood; C B Nemeroff
Journal:  Arch Gen Psychiatry       Date:  1992-07
View more
  14 in total

1.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

2.  Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease.

Authors:  Robert Christian Wolf; Philipp Arthur Thomann; Fabio Sambataro; Nadine Donata Wolf; Nenad Vasic; G Bernhard Landwehrmeyer; Sigurd Dietrich Süßmuth; Michael Orth
Journal:  J Neurol       Date:  2015-01-28       Impact factor: 4.849

3.  Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.

Authors:  Eric A Epping; James A Mills; Leigh J Beglinger; Jess G Fiedorowicz; David Craufurd; Megan M Smith; Mark Groves; Kelly R Bijanki; Nancy Downing; Janet K Williams; Jeffrey D Long; Jane S Paulsen
Journal:  J Psychiatr Res       Date:  2013-06-19       Impact factor: 4.791

4.  Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography.

Authors:  Christos Krogias; Katrin Strassburger; Jens Eyding; Ralf Gold; Christine Norra; Georg Juckel; Carsten Saft; Dietmar Ninphius
Journal:  J Psychiatry Neurosci       Date:  2011-05       Impact factor: 6.186

5.  Irritability in pre-clinical Huntington's disease.

Authors:  Stefan Klöppel; Cynthia M Stonnington; Predrag Petrovic; Dean Mobbs; Oliver Tüscher; David Craufurd; Sarah J Tabrizi; Richard S J Frackowiak
Journal:  Neuropsychologia       Date:  2009-10-28       Impact factor: 3.139

6.  Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.

Authors:  Ferdinando Squitieri; Sara Orobello; Milena Cannella; Tiziana Martino; Pantaleo Romanelli; Giampiero Giovacchini; Luigi Frati; Luigi Mansi; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-11       Impact factor: 9.236

7.  Emotional blunting following left basal ganglia stroke: the role of depression and fronto-limbic functional alterations.

Authors:  Sergio Paradiso; Katharine Ostedgaard; Jatin Vaidya; Laura Boles Ponto; Robert Robinson
Journal:  Psychiatry Res       Date:  2012-11-21       Impact factor: 3.222

8.  Depression in the early stages of Huntington disease.

Authors:  Eric A Epping; Jane S Paulsen
Journal:  Neurodegener Dis Manag       Date:  2011-10-01

9.  Sex-dependent changes in social behaviors in motor pre-symptomatic R6/1 mice.

Authors:  Susanna Pietropaolo; Pauline Delage; Sebastien Cayzac; Wim E Crusio; Yoon H Cho
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

10.  Genetic deletion of the Histone Deacetylase 6 exacerbates selected behavioral deficits in the R6/1 mouse model for Huntington's disease.

Authors:  Alienor Ragot; Susanna Pietropaolo; Jean Vincent; Pauline Delage; Hongyu Zhang; Bernadette Allinquant; Xavier Leinekugel; André Fischer; Yoon H Cho
Journal:  Brain Behav       Date:  2015-06-24       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.